Overview and evaluation of a nationwide hospital-based surveillance system for influenza and COVID-19 in Switzerland (CH-SUR): 2018-2023.
Jonathan Sobel(University Hospital of Geneva), Olivia Keiser(University of Geneva), Anne Iten(University Hospital of Geneva), Peter W. Schreiber(University Hospital of Zurich), Davide Giovanni Bosetti(Institute of Oncology Research), Didier Pittet(Hôpital Beau-Séjour), Alexia Cusini(Spital Thurgau (Switzerland)), Ulrich Heininger(University Children’s Hospital Basel), Camille B. Valera(University of Geneva), Rebecca Grant(University Hospital of Geneva), Marie-Céline Zanella(University of Geneva), Petra Zimmermann(University of Fribourg), Khaled Mostaguir(SIB Swiss Institute of Bioinformatics), Sara Escobar Botero, Rami Sommerstein, Philipp Jent(University of Bern), Laura Urbini(University of Geneva), Ursina Roder(Federal Office of Public Health), Stephan Harbarth, Anita Niederer-Loher, Maria Suveges, Domenica Flury
Cited by 0
Related Papers
ExPASy: SIB bioinformatics resource portal
|Nucleic Acids Research|2012|2.4k
Cancer Risk in the Swiss HIV Cohort Study: Associations With Immunodeficiency, Smoking, and Highly Active Antiretroviral Therapy
|JNCI Journal of the National Cancer Institute|2005|857
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial
|The Lancet|2007|689
Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections
|Archives of Disease in Childhood|2020|534
Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum
|Antimicrobial Resistance and Infection Control|2013|454